General Statement of Disclosure:
SPEAKER'S BUREAU: Amarin(SIGNIFICANT), Amgen(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: General Electric(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT)
